학술논문
Real‐world experience of nivolumab in the treatment of poor performance status patients with advanced non‐small cell lung cancer.
Document Type
Article
Author
Source
Cancer Reports; Mar2022, Vol. 5 Issue 3, p1-6, 6p
Subject
Language
ISSN
25738348